Engaging American Indians in cancer genome sequencing
Participant Engagement - Cancer Genome Sequencing (PE-CGS) Research Center: Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
This study is trying to find better ways to involve American Indians in Southwestern Tribal Nations in cancer research by looking at their genetic information to help improve cancer prevention and treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1001 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | New Mexico Cancer Research Alliance Academic / other |
| Locations | 1 site (Albuquerque, New Mexico) |
| Trial ID | NCT06207864 on ClinicalTrials.gov |
What this trial studies
This clinical trial focuses on developing culturally appropriate strategies to engage and recruit American Indians from Southwestern Tribal Nations for cancer genome sequencing. It aims to understand the genetic changes that lead to higher cancer rates in this population by directly involving cancer patients, survivors, and community advisors in the research process. The study will collect tumor samples and relevant data while providing participants with genomic results and access to counseling resources. The goal is to enhance prevention and treatment strategies for cancer among American Indians in the Southwest.
Who should consider this trial
Good fit: Ideal candidates for this study are adult American Indian cancer patients undergoing treatment or cancer survivors from Southwestern Tribal Nations.
Not a fit: Patients who are cognitively impaired or unable to consent for themselves will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and treatment of cancer in American Indian populations.
How similar studies have performed: While this approach is tailored to a specific population, similar engagement strategies in other studies have shown promise in improving recruitment and outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The PE-CGS Research Center is only recruiting and sequencing tumors for adult-onset cancers (patients and survivors) among the American Indian Tribes, Nations, and Pueblos of New Mexico and adjacent states * Male or female adults (18 years) or older * Cancer patient undergoing active treatment or a cancer survivor * Self-identify as American Indian Exclusion Criteria: * Cognitively impaired * Adults unable to consent for themselves * Individuals who are not yet adults * Prisoners
Where this trial is running
Albuquerque, New Mexico
- University of New Mexico Comprehensive Cancer Center — Albuquerque, New Mexico, United States (Recruiting)
Study contacts
- Principal investigator: Cheryl Willman, MD — University of New Mexico Comprehensive Cancer Center
- Study coordinator: Andrew Sussman, PhD
- Email: ASussman@salud.unm.edu
- Phone: (505) 272-4077
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.